Correlation Between Vyne Therapeutics and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Organon Co, you can compare the effects of market volatilities on Vyne Therapeutics and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Organon.

Diversification Opportunities for Vyne Therapeutics and Organon

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Vyne and Organon is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Organon go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and Organon

Given the investment horizon of 90 days Vyne Therapeutics is expected to under-perform the Organon. In addition to that, Vyne Therapeutics is 2.75 times more volatile than Organon Co. It trades about -0.04 of its total potential returns per unit of risk. Organon Co is currently generating about -0.02 per unit of volatility. If you would invest  1,662  in Organon Co on November 2, 2024 and sell it today you would lose (65.00) from holding Organon Co or give up 3.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vyne Therapeutics  vs.  Organon Co

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Organon is not utilizing all of its potentials. The new stock price disarray, may contribute to short-term losses for the investors.

Vyne Therapeutics and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and Organon

The main advantage of trading using opposite Vyne Therapeutics and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Vyne Therapeutics and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like